In vitro comparison of spatiotemporal fibrin clot formation dynamics in plasma treated with different protamine-heparin ratios.
Richard WargowskyJessica ZvaraNidal QaddumiAlberto Gonzalez-AlmadaDora LinXiomara FernandezKenichi TanakaMichael A MazzeffiPublished in: Perfusion (2022)
Plasma samples treated with a low protamine-heparin ratio had superior clot growth velocity and larger clot size at 30 min compared to a one-to-one ratio, supporting the notion that a low protamine-heparin ratio may optimize enzymatic coagulation after cardiopulmonary bypass.